查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606719

數位 PCR 和即時PCR市場：按類型、產品類型、應用和最終用戶 - 2025-2030 年全球預測

Digital PCR & Real-Time PCR Market by Type (dPCR, qPCR), Product Type (Instruments, Reagents & Consumables, Services), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年數位PCR和即時PCR市場價值為82.4億美元，預計到2024年將達到88.7億美元，複合年成長率為7.98%，到2030年將達到141.1億美元。

數位 PCR (dPCR) 和即時PCR(qPCR) 市場重點關注用於準確定量 DNA 和 RNA 擴增的分子生物學技術。兩者在診斷、研究和應用科學中都發揮著重要作用。遺傳疾病檢測、癌症研究、病原體檢測（包括COVID-19）和基因分型等領域的應用凸顯了對這些技術的需求，並廣泛應用於醫院、診斷中心、研究機構等。各領域用戶。主要成長動力包括生物技術的進步、感染疾病的傳播、個人化醫療需求的增加以及基因組研究資金的增加。機會在於提高靈敏度和準確性、自動化以及人工智慧對資料解釋的整合，從而推動更廣泛的採用和創新。

主要市場統計
基準年[2023] 82.4億美元
預測年份 [2024] 88.7億美元
預測年份 [2030] 141.1億美元
複合年成長率（%） 7.98%

挑戰源於設備和試劑的高成本、技術複雜性以及對熟練人員的需求，這可能會限制獲取，特別是在發展中地區。專注於負擔得起且方便用戶使用的解決方案的新興市場參與者正在部分解決這個問題。此外，監管障礙和不同的地區報銷框架繼續阻礙因素成長。然而，可攜式和照護現場PCR 設備的技術創新和改進的多重功能是業務擴展的一個有希望的領域。市場競爭的特點是注重研發和策略合併，以加強產品供應和簡化供應鏈。公司可以利用 PCR 檢測中擴大採用微射流和奈米技術等趨勢來提高通量和準確性。次世代定序儀定序和環境永續技術探索的整合可以提供競爭優勢和新的收益來源。產業相關人員可以隨時了解監管環境的變化，利用與學術研究機構的合作夥伴關係，開拓克服挑戰並利用快速發展的數位和即時PCR技術領域的成長機會。

市場動態：揭示快速發展的數位 PCR 和即時PCR市場的關鍵市場洞察

供應和需求的動態相互作用正在改變數位 PCR 和即時PCR市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • dPCR和qPCR在臨床病毒學診斷的優勢
    • 遺傳性疾病和感染疾病的增加
    • dPCR和qPCR在植物來源產品認證的應用
  • 市場限制因素
    • dPCR 和 qPCR 技術的嚴格監管指南
  • 市場機會
    • 液滴數位 PCR (ddPCR) 技術的出現
    • dPCR 和 qPCR 在生物標記發現的應用的出現
  • 市場挑戰
    • 與 dPCR 和 qPCR 技術相關的局限性

波特五力：駕馭數位 PCR 和即時PCR市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解數位 PCR 和即時PCR市場的外部影響

外部宏觀環境因素在塑造數位 PCR 和即時PCR市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解數位 PCR 和即時PCR市場的競爭格局

對數位 PCR 和即時PCR市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 數位 PCR 和即時PCR市場中的定位矩陣供應商績效評估

FPNV定位矩陣是評估數位PCR和即時PCR市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製數位 PCR 和即時PCR市場的成功之路

數位 PCR 和即時PCR市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、核准核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • dPCR和qPCR在臨床病毒診斷上的優勢
      • 遺傳性疾病和感染疾病的發生率增加
      • dPCR和qPCR在植物來源產品認證的應用
    • 抑制因素
      • dPCR 和 qPCR 技術的嚴格監管指南
    • 機會
      • 液滴數位 PCR (ddPCR) 技術的出現
      • dPCR 和 qPCR 在生物標記發現的新應用
    • 任務
      • 與 dPCR 和 qPCR 技術相關的局限性
  • 市場區隔分析
    • 類型：高通量和寬動態範圍的首選 qPCR
    • 產品類型：對滿足專業最終用戶需求的特定應用套件的需求不斷成長
    • 應用：在法醫學中用於親子鑑定和犯罪現場調查中低水平 DNA 檢測的巨大潛力
    • 最終使用者：dPCR 和 qPCR 在個人化藥物開發的關鍵應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章數位 PCR 和即時PCR市場：按類型

  • dPCR
  • 定量PCR

第7章數位 PCR 和即時PCR市場：依產品類型

  • 裝置
  • 試劑/耗材
  • 服務

第 8 章數位 PCR 和即時PCR市場：按應用分類

  • 臨床調查
  • 法醫學研究所
  • 調查機構

第 9 章 數位 PCR 和即時PCR市場：按最終用戶分類

  • 學術研究所
  • 農業與生命科學
  • CRO 和 CDMO
  • 醫院和診斷實驗室
  • 製藥和生物製藥公司

第10章美洲數位PCR與即時PCR市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太數位PCR與即時PCR市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的數位PCR和即時PCR市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • QIAGEN 推出 QIAcuity 平台的先進數位 PCR 檢測設計工具，提升分子診斷的客製化性和準確性
    • Bio-Rad 推出超靈敏數位 PCR 檢測，開創了乳癌先進突變檢測和個人化治療的先河
    • 羅氏推出新一代 qPCR 系統，以改善臨床需求並應對分子診斷的公共衛生挑戰
    • QIAGEN 推出新的 QIAcuity 數位 PCR套件和更新的軟體，以擴大生物製藥和食品安全客戶的使用範圍
    • Seegene 和 Werfen 合作開發綜合症qPCR篩檢
  • 戰略分析和建議

公司名單

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH+Co. KG by Endress+Hauser Group Services AG
  • Azure Biosystems Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocompare by CompareNetworks, Inc.
  • BIOMERIEUX SA
  • Bioneer Corporation
  • Danaher Corporation
  • ELITech Group by Bruker Corp
  • Enzo Life Sciences, Inc.
  • Eppendorf SE
  • Etcon Analytical and Environmental Systems & Services Ltd.
  • Explorea sro
  • F. Hoffmann-La Roche AG
  • Global Engage Sdn. Bhd.
  • Hangzhou Longgene Scientific Instruments Co., Ltd.
  • Heal Force Bio-Meditech Holdings Limited
  • LABGENE Scientific SA
  • Merck KGaA
  • Meridian Bioscience, Inc. by SD Biosensor, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Quidel Corporation
  • R-Biopharm AG
  • RainSure Scientific
  • Roche Diagnostics Corporation
  • Solis BioDyne OU
  • STANDARD BIOTOOLS INC.
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp
Product Code: MRR-8760467AA4C1

The Digital PCR & Real-Time PCR Market was valued at USD 8.24 billion in 2023, expected to reach USD 8.87 billion in 2024, and is projected to grow at a CAGR of 7.98%, to USD 14.11 billion by 2030.

The digital PCR (dPCR) and real-time PCR (qPCR) markets focus on molecular biology techniques used for precise and quantitative amplification of DNA and RNA. Both play crucial roles in diagnostics, research, and applied sciences. The necessity for these technologies is underscored by their applications in detecting genetic disorders, cancer research, pathogen detection (including COVID-19), and genotyping, which expand their scope across diverse end-users such as hospitals, diagnostic centers, and research institutions. The key growth drivers include advancements in biotechnology, a growing prevalence of infectious diseases, increased demand for personalized medicine, and enhanced funding for genomics research. Opportunities lie in enhancements in sensitivity and accuracy, automation, and integration of AI for data interpretation, facilitating broader adoption and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 8.24 billion
Estimated Year [2024] USD 8.87 billion
Forecast Year [2030] USD 14.11 billion
CAGR (%) 7.98%

Challenges stem from the high costs of equipment and reagents, technical complexities, and the need for skilled personnel, which may limit accessibility, especially in developing regions. This is addressed partially by emerging market players focusing on affordable and user-friendly solutions. Furthermore, regulatory hurdles and variability in reimbursement frameworks across regions continue to pose growth impediments. Nevertheless, innovations in portable and point-of-care PCR devices and improvements in multiplexing capabilities are promising areas for business expansion. The market's competitive nature is characterized by a focus on R&D and strategic mergers to bolster product offerings and streamline supply chains. Businesses can leverage trends like the increasing adoption of microfluidics and nanotechnology in PCR assays to enhance throughput and precision. Researching into next-gen sequencing integrations and environmentally sustainable technologies could provide competitive advantages and new revenue streams. It is essential for industry players to stay informed of regulatory changes, leverage collaborations with academic and research bodies, and continue exploring emerging markets to overcome challenges and capitalize on growth opportunities within the rapidly evolving landscape of digital and real-time PCR technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital PCR & Real-Time PCR Market

The Digital PCR & Real-Time PCR Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Benefits of dPCR & qPCR for clinical virology diagnostics
    • Increasing incidences of genetic and infectious diseases
    • Applications of dPCR & qPCR in authenticating plant-derived products
  • Market Restraints
    • Stringent regulatory guidelines regarding dPCR & qPCR techniques
  • Market Opportunities
    • Emergence of droplet digital PCR (ddPCR) technology
    • Emerging applications of dPCR & qPCR in biomarker discovery
  • Market Challenges
    • Limitations associated with dPCR & qPCR techniques

Porter's Five Forces: A Strategic Tool for Navigating the Digital PCR & Real-Time PCR Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital PCR & Real-Time PCR Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital PCR & Real-Time PCR Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital PCR & Real-Time PCR Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital PCR & Real-Time PCR Market

A detailed market share analysis in the Digital PCR & Real-Time PCR Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital PCR & Real-Time PCR Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital PCR & Real-Time PCR Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital PCR & Real-Time PCR Market

A strategic analysis of the Digital PCR & Real-Time PCR Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital PCR & Real-Time PCR Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Inc., Agilent Technologies, Inc., Analytik Jena GmbH+Co. KG by Endress+Hauser Group Services AG, Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocompare by CompareNetworks, Inc., BIOMERIEUX S.A., Bioneer Corporation, Danaher Corporation, ELITech Group by Bruker Corp, Enzo Life Sciences, Inc., Eppendorf SE, Etcon Analytical and Environmental Systems & Services Ltd., Explorea s.r.o, F. Hoffmann-La Roche AG, Global Engage Sdn. Bhd., Hangzhou Longgene Scientific Instruments Co., Ltd., Heal Force Bio-Meditech Holdings Limited, LABGENE Scientific SA, Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor, Inc., Promega Corporation, QIAGEN N.V., Quidel Corporation, R-Biopharm AG, RainSure Scientific, Roche Diagnostics Corporation, Solis BioDyne OU, STANDARD BIOTOOLS INC., Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp.

Market Segmentation & Coverage

This research report categorizes the Digital PCR & Real-Time PCR Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across dPCR and qPCR.
  • Based on Product Type, market is studied across Instruments, Reagents & Consumables, and Services.
  • Based on Application, market is studied across Clinical Research, Forensic Labs, and Research Institutes.
  • Based on End-User, market is studied across Academic & Research Institutes, Agriculture & Lifescience, CROs & CDMOs, Hospitals & Diagnostic Laboratories, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Benefits of dPCR & qPCR for clinical virology diagnostics
      • 5.1.1.2. Increasing incidences of genetic and infectious diseases
      • 5.1.1.3. Applications of dPCR & qPCR in authenticating plant-derived products
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory guidelines regarding dPCR & qPCR techniques
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of droplet digital PCR (ddPCR) technology
      • 5.1.3.2. Emerging applications of dPCR & qPCR in biomarker discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with dPCR & qPCR techniques
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Higher preferences for qPCR for high throughput and a broader dynamic range
    • 5.2.2. Product Type: Growing demand for application-specific kits that address the needs of specialized end-users
    • 5.2.3. Application: Higher potential in forensics for paternity testing and the detection of low-level DNA in crime scene investigations
    • 5.2.4. End-User: Significant applications of dPCR & qPCR in the personalized drug development he
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital PCR & Real-Time PCR Market, by Type

  • 6.1. Introduction
  • 6.2. dPCR
  • 6.3. qPCR

7. Digital PCR & Real-Time PCR Market, by Product Type

  • 7.1. Introduction
  • 7.2. Instruments
  • 7.3. Reagents & Consumables
  • 7.4. Services

8. Digital PCR & Real-Time PCR Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Research
  • 8.3. Forensic Labs
  • 8.4. Research Institutes

9. Digital PCR & Real-Time PCR Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Agriculture & Lifescience
  • 9.4. CROs & CDMOs
  • 9.5. Hospitals & Diagnostic Laboratories
  • 9.6. Pharmaceutical & Biopharmaceutical Companies

10. Americas Digital PCR & Real-Time PCR Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Digital PCR & Real-Time PCR Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Digital PCR & Real-Time PCR Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. QIAGEN Introduces Advanced Digital PCR Assay Design Tool for QIAcuity Platform, Boosting Customization and Precision in Molecular Diagnostics
    • 13.3.2. Bio-Rad Unveils Ultrasensitive Digital PCR Assay, Pioneering Advanced Breast Cancer Mutation Detection and Personalized Treatment
    • 13.3.3. Roche Launches Next-Generation qPCR System to Advance Clinical Needs in Molecular Diagnostics and Address Public Health Challenges
    • 13.3.4. QIAGEN Launches New QIAcuity Digital PCR Kits and Updated Software to Expand Use by Biopharma and Food Safety Customers
    • 13.3.5. Seegene and Werfen Partner on Syndromic qPCR Assays Development
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Analytik Jena GmbH+Co. KG by Endress+Hauser Group Services AG
  • 4. Azure Biosystems Inc.
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Biocompare by CompareNetworks, Inc.
  • 8. BIOMERIEUX S.A.
  • 9. Bioneer Corporation
  • 10. Danaher Corporation
  • 11. ELITech Group by Bruker Corp
  • 12. Enzo Life Sciences, Inc.
  • 13. Eppendorf SE
  • 14. Etcon Analytical and Environmental Systems & Services Ltd.
  • 15. Explorea s.r.o
  • 16. F. Hoffmann-La Roche AG
  • 17. Global Engage Sdn. Bhd.
  • 18. Hangzhou Longgene Scientific Instruments Co., Ltd.
  • 19. Heal Force Bio-Meditech Holdings Limited
  • 20. LABGENE Scientific SA
  • 21. Merck KGaA
  • 22. Meridian Bioscience, Inc. by SD Biosensor, Inc.
  • 23. Promega Corporation
  • 24. QIAGEN N.V.
  • 25. Quidel Corporation
  • 26. R-Biopharm AG
  • 27. RainSure Scientific
  • 28. Roche Diagnostics Corporation
  • 29. Solis BioDyne OU
  • 30. STANDARD BIOTOOLS INC.
  • 31. Takara Bio USA, Inc.
  • 32. Thermo Fisher Scientific Inc.
  • 33. Zymo Research Corp

LIST OF FIGURES

  • FIGURE 1. DIGITAL PCR & REAL-TIME PCR MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIGITAL PCR & REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIGITAL PCR & REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL PCR & REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL PCR & REAL-TIME PCR MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DPCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY AGRICULTURE & LIFESCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CROS & CDMOS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. DIGITAL PCR & REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. DIGITAL PCR & REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2023